Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommerer

Showing results (381-390 of 427) with videos related to

Pageof 43
Sort By:
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2017
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trialKlemens Budde, Martin Zeier, Oliver Witzke, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
The New England Journal of Medicine|June 29, 2010
Everolimus in patients with autosomal dominant polycystic kidney diseaseGerd Walz, Klemens Budde, Marwan Mannaa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2015
Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Jens Nürnberger, et al.
Transplantation|October 24, 2008
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trialTeun van Gelder, Helio Tedesco Silva, Johan W de Fijter, et al.
Journal of Neurochemistry|April 9, 2005
Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicityBruno Conti, Shuei Sugama, Jacinta Lucero, et al.
Journal of Clinical Medicine|March 28, 2020
Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-StudyMoritz Mirna, Albert Topf, Bernhard Wernly, et al.
Journal of Critical Care|December 4, 2014
Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shockDaniel O Thomas-Rueddel, Bernhard Poidinger, Manfred Weiss, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
Pageof 43

Showing results (381-390 of 427) with videos related to

Sort By:
Pageof 43
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2017
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trialKlemens Budde, Martin Zeier, Oliver Witzke, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
The New England Journal of Medicine|June 29, 2010
Everolimus in patients with autosomal dominant polycystic kidney diseaseGerd Walz, Klemens Budde, Marwan Mannaa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2015
Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Jens Nürnberger, et al.
Transplantation|October 24, 2008
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trialTeun van Gelder, Helio Tedesco Silva, Johan W de Fijter, et al.
Journal of Neurochemistry|April 9, 2005
Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicityBruno Conti, Shuei Sugama, Jacinta Lucero, et al.
Journal of Clinical Medicine|March 28, 2020
Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-StudyMoritz Mirna, Albert Topf, Bernhard Wernly, et al.
Journal of Critical Care|December 4, 2014
Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shockDaniel O Thomas-Rueddel, Bernhard Poidinger, Manfred Weiss, et al.
Journal of the American Society of Nephrology : JASN|May 13, 2018
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal TransplantationJulio Pascual, Stefan P Berger, Oliver Witzke, et al.
Pageof 43